Novel Kidney Injury Biomarkers

被引：4
作者：
Adler, Sharon [1 ]
机构：
[1] Harbor UCLA Med Ctr, Div Nephrol & Hypertens, Torrance, CA 90509 USA
来源：
JOURNAL OF RENAL NUTRITION | 2010年 / 20卷 / 05期
关键词：
SERUM CYSTATIN-C; TYPE-2; DIABETES/; DISEASE; MARKER; OSTEOACTIVIN; NEPHROPATHY; IRBESARTAN; CREATININE; RISK; CKD;
D O I：
10.1053/j.jrn.2010.05.005
中图分类号：
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号：
100403 ;
摘要：
New biomarkers are currently under development for acute kidney injury and chronic kidney disease. Panels of validated biomarkers are most likely to be required to obtain information that will help in delineating acute versus chronic disease, the pathogenetic nature of the process, the severity, and the capacity for reversibility. Glycoprotein non-metastatic melanoma protein-b, a protein associated with regulation of inflammation and autophagy, is in an intermediate stage of development as a kidney injury biomarker. (C) 2010 by the National Kidney Foundation, Inc. All rights reserved.
引用
收藏
页码：S15 / S18
页数：4
相关论文
共 25 条
[1]   Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function [J].
Abdelmagid, Samir M. ;
Barbe, Mary F. ;
Rico, Mario C. ;
Salihoglu, Sibel ;
Arango-Hisijara, Israel ;
Selim, Abdul Hafez ;
Anderson, Michael G. ;
Owen, Thomas A. ;
Popoff, Steven N. ;
Safadi, Fayez F. .
EXPERIMENTAL CELL RESEARCH, 2008, 314 (13) :2334-2351
[2]  
BACHNER D, 2002, GENE EXPR PATTERNS, V1, P159
[3]  
Bakoush O, 2008, CLIN NEPHROL, V69, P331
[4]   Why choose serum cystatin C levels over serum creatinine levels as a serologic marker of kidney function? [J].
Ben-Dov, Iddo Z. .
ANNALS OF INTERNAL MEDICINE, 2008, 149 (04) :284-284
[5]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[6]  
Büchner N, 2008, NEW ENGL J MED, V359, P426, DOI 10.1056/NEJMc081065
[7]   Qualification of biomarkers for drug development in organ transplantation [J].
Burckart, Gilbert J. ;
Amur, Shashi ;
Goodsaid, Federico M. ;
Lesko, Lawrence J. ;
Frueh, Felix W. ;
Huang, Shiew-Mei ;
Cavaille-Coll, Marc W. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (02) :267-270
[8]   DC-HIL is a negative regulator of T lymphocyte activation [J].
Chung, Jin-Sung ;
Sato, Kota ;
Dougherty, Irene I. ;
Cruz, Ponciano D., Jr. ;
Ariizumi, Kiyoshi .
BLOOD, 2007, 109 (10) :4320-4327
[9]   Biomarkers for the diagnosis and risk stratification of acute kidney injury: A systematic review [J].
Coca, S. G. ;
Yalavarthy, R. ;
Concato, J. ;
Parikh, C. R. .
KIDNEY INTERNATIONAL, 2008, 73 (09) :1008-1016
[10]   New data on the intraindividual variation of cystatin C [J].
Delanaye, Pierre ;
Cavalier, Etienne ;
Depas, Gisele ;
Chapelle, Jean-Paul ;
Krzesinski, Jean-Marie .
NEPHRON CLINICAL PRACTICE, 2008, 108 (04) :C246-C248
123